Description

Triple negative breast cancer is a heterogeneous disease with distinct molecular subtypes that differentially respond to chemotherapy and targeted agents. The purpose of this study was to explore the clinical relevance of Lehmann triple negative breast cancer subtypes by identifying any differences in response to neoadjuvant chemotherapy among them.

Publication Title

Triple negative breast cancer subtypes and pathologic complete response rate to neoadjuvant chemotherapy.

Sample Metadata Fields

Specimen part, Treatment